Add Yahoo as a preferred source to see more of our stories on Google. Aug. 1—JACKSONVILLE, Fla. — Mayo Clinic is the first U.S. health system to treat a case of breast cancer with a new radioactive ...

Theralase Technologies (TSXV:TLT) has shown in pre-clinical trials that its flagship Rutherrin, when activated by X-Ray, is ...

Actinium-225, an alpha-emitting radiopharmaceutical, targets cancer cells precisely, sparing healthy tissue, and is being trialed for advanced breast cancer in the U.S. The phase 1b/2 trial involves ...

Prostate cancer is the leading cancer among Kenyan men, with an estimated 3,582 men being diagnosed with the disease at some ...

It may be best not to go off-script when it comes to breast cancer. Roughly 1 in 8 US women are expected to be diagnosed with invasive breast cancer at some point. It’s the most common cancer in women ...

A pill has been shown to help keep certain early-stage, hard-to-treat breast cancers at bay after initial treatment in findings being reported early because they are so promising. Study results were ...

JACKSONVILLE, Fla. — Mayo Clinic is the first U.S. health system to treat a case of breast cancer with a new radioactive treatment, it announced Friday, Aug. 1. The medicine contains actinium-225, a ...